Last news
NAVER D2SF Invests in Clone Labs, an AI Startup That Predicts User Intent and Decisions

NAVER D2SF Invests in Clone Labs, an AI Startup That Predicts User Intent and Decisions

- Developing a "User Model" that records and accumulates users' computer and agent usage patterns in real time to predict next actions - NAVER D2SF continues to back founders identifying new opportunities emerging from the AI paradigm shift...

Innovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences

Innovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences

SAN FRANCISCO and SUZHOU, China, May 19, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

Inference Room ships Tack, pledges at least one AI Agent product every month

Inference Room ships Tack, pledges at least one AI Agent product every month

Tack, an Agent-native storage and memory layer, is Inference Room's first product LONDON and SINGAPORE, May 19, 2026 /PRNewswire/ -- Inference Room launched last week as a launchpad for AI Agents and AI Agent infrastructure. Its first resident,...

Govee Presents Sanctuary, Reimagining the Modern Home Through Floor Lamps, Colour and Design

Govee Presents Sanctuary, Reimagining the Modern Home Through Floor Lamps, Colour and Design

Created with celebrity interior designer Fawn Galli, the one-night showcase introduced Govee's latest Floor Lamp Series through styled home settings A panel discussion explored how lighting, colour and design can help homes feel more flexible,...

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached with no dose-limiting toxicities observed. TLX101-Tx is also the subject of a pivotal trial, IPAX BrIGHT, which is actively dosing patients with...

Yalla Group Limited Announces Unaudited First Quarter 2026 Financial Results

Yalla Group Limited Announces Unaudited First Quarter 2026 Financial Results

DUBAI, UAE, May 19, 2026 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results...

OMAN'S SOVEREIGN FUND JOINS GLOBAL TOP PERFORMERS AS RETURNS HIT RECORD HIGH

OMAN'S SOVEREIGN FUND JOINS GLOBAL TOP PERFORMERS AS RETURNS HIT RECORD HIGH

Oman Investment Authority reports USD 7.8bn profit and leads worldwide in public market performance MUSCAT, Oman, May 19, 2026 /PRNewswire/ -- Oman Investment Authority, the Sultanate of Oman's sovereign wealth fund, has reported its strongest...

DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION

DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION

Dave & Buster's makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights First Dave & Buster's location in Australia opens in Perth. New venue combines dining, sports viewing and competitive social gaming under one...

menu
menu